Pediatric Brainstem Gangliogliomas Show BRAF(V600E) Mutation in a High Percentage of Cases

Brainstem gangliogliomas (GGs), often cannot be resected, have a much poorer prognosis than those located in more common supratentorial sites and may benefit from novel therapeutic approaches. Therapeutically targetable BRAF c.1799 T>A (p.V600E) (BRAF(V600E)) mutations are harbored in roughly 50%...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Donson, Andrew M., Kleinschmidt‐DeMasters, Bette K., Aisner, Dara L., Bemis, Lynne T., Birks, Diane K., Levy, Jean M. Mulcahy, Smith, Amy A., Handler, Michael H., Foreman, Nicholas K., Rush, Sarah Z.
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2013
Sujets:
Research Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4025990/
https://ncbi.nlm.nih.gov/pubmed/24238153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bpa.12103
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires